Fenofibrate and diabetic retinopathy

Clin Exp Ophthalmol. 2015 May-Jun;43(4):297-9. doi: 10.1111/ceo.12539.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Australia
  • Diabetic Retinopathy / diagnosis
  • Diabetic Retinopathy / drug therapy*
  • Disease Progression
  • Drug Costs
  • Fenofibrate / adverse effects
  • Fenofibrate / economics
  • Fenofibrate / therapeutic use*
  • Humans
  • Hyperlipidemias / drug therapy
  • Hypolipidemic Agents / adverse effects
  • Hypolipidemic Agents / economics
  • Hypolipidemic Agents / therapeutic use*
  • Randomized Controlled Trials as Topic
  • Sex Factors

Substances

  • Hypolipidemic Agents
  • Fenofibrate